You are viewing a single comment's thread from:

RE: Critical evaluation of CRISPR/Cas9 gene editing technology and the power to cure genetic diseases with gene editing drugs

in StemSocial2 years ago

I concur with you on this.
Though most times, competition tend to reduce the cost at the long run.

But for the time being, let the rich flex their muscle.

Sort:  

That's true. The rich in developed countries will flex their muscles, followed by the masses in developed countries, then it would find its way down to developing countries in years or maybe decades. Ventilator is a very good example. If it weren't for Covid-19, so many hospitals in developing countries won't have good, functioning ventilators.